These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 8057484
1. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484 [Abstract] [Full Text] [Related]
2. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. Komano J, Sugiura M, Takada K. J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461 [Abstract] [Full Text] [Related]
3. Pathogenic role of Epstein-Barr virus in human cancer. Takada K, Shimizu N, Tanabe-Tochikura A, Kuroiwa Y. Intervirology; 1995 Nov; 38(3-4):214-20. PubMed ID: 8682619 [Abstract] [Full Text] [Related]
4. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD, Rowe M, Rickinson AB. J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [Abstract] [Full Text] [Related]
5. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. Komano J, Maruo S, Kurozumi K, Oda T, Takada K. J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294 [Abstract] [Full Text] [Related]
6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB. Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [Abstract] [Full Text] [Related]
7. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata. Komano J, Takada K. J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530 [Abstract] [Full Text] [Related]
8. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle. Evans TJ, Jacquemin MG, Farrell PJ. Virology; 1995 Feb 01; 206(2):866-77. PubMed ID: 7856099 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K. EMBO J; 2000 Dec 15; 19(24):6742-50. PubMed ID: 11118209 [Abstract] [Full Text] [Related]
10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR. Eur J Immunol; 1995 May 15; 25(5):1374-84. PubMed ID: 7774641 [Abstract] [Full Text] [Related]
11. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S. Virus Genes; 1991 Apr 15; 5(2):147-56. PubMed ID: 1647567 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT. J Virol; 2000 Nov 15; 74(21):10223-8. PubMed ID: 11024153 [Abstract] [Full Text] [Related]
13. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells. Maruo S, Nanbo A, Takada K. J Virol; 2001 Oct 15; 75(20):9977-82. PubMed ID: 11559830 [Abstract] [Full Text] [Related]
14. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM. Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda. Olweny CL, Atine I, Kaddu-Mukasa A, Owor R, Andersson-Anvret M, Klein G, Henle W, de-Thé G. J Natl Cancer Inst; 1977 May 01; 58(5):1191-6. PubMed ID: 192894 [Abstract] [Full Text] [Related]
16. Role of Epstein-Barr virus in Burkitt's lymphoma. Takada K. Curr Top Microbiol Immunol; 2001 May 01; 258():141-51. PubMed ID: 11443859 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. EMBO J; 2002 Mar 01; 21(5):954-65. PubMed ID: 11867523 [Abstract] [Full Text] [Related]
18. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule. Abe M, Tasaki K, Tominaga K, Fukuhara S, Imai S, Osato T, Wakasa H. Cancer; 1992 Feb 01; 69(3):763-71. PubMed ID: 1309680 [Abstract] [Full Text] [Related]
19. Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line. Shi M, Gan YJ, Davis TO, Scott RS. Virus Res; 2013 Oct 01; 177(1):11-21. PubMed ID: 23891576 [Abstract] [Full Text] [Related]
20. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. Rooney C, Howe JG, Speck SH, Miller G. J Virol; 1989 Apr 01; 63(4):1531-9. PubMed ID: 2538644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]